With sales team sidelined by COVID-19, Pfizer braces for a second-quarter revenue hit
admin 28th April 2020 Uncategorised 0With a looming spinoff of its underperforming Upjohn generics business, Pfizer is working to get its branded drug unit in shape to strike out on its own. But with the novel coronavirus pandemic hamstringing its sales team, Pfizer might be due for a world of hurt in the coming quarter.
More: With sales team sidelined by COVID-19, Pfizer braces for a second-quarter revenue hit
Source: fierce